Growth Metrics

Pfizer (PFE) Preferred Shares (2016 - 2020)

Pfizer (PFE) has disclosed Preferred Shares for 12 consecutive years, with $17.0 million as the latest value for Q1 2020.

  • Quarterly Preferred Shares fell 10.53% to $17.0 million in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $17.0 million through Mar 2020, down 10.53% year-over-year, with the annual reading at $17.0 million for FY2019, 10.53% down from the prior year.
  • Preferred Shares for Q1 2020 was $17.0 million at Pfizer, roughly flat from $17.0 million in the prior quarter.
  • The five-year high for Preferred Shares was $26.0 million in Q2 2016, with the low at $17.0 million in Q4 2019.
  • Average Preferred Shares over 5 years is $21.1 million, with a median of $21.0 million recorded in 2017.
  • The sharpest move saw Preferred Shares dropped 7.14% in 2016, then dropped 13.04% in 2018.
  • Over 5 years, Preferred Shares stood at $24.0 million in 2016, then decreased by 12.5% to $21.0 million in 2017, then dropped by 9.52% to $19.0 million in 2018, then dropped by 10.53% to $17.0 million in 2019, then changed by 0.0% to $17.0 million in 2020.
  • According to Business Quant data, Preferred Shares over the past three periods came in at $17.0 million, $17.0 million, and $18.0 million for Q1 2020, Q4 2019, and Q3 2019 respectively.